Health & Wellness
Sunday, July 19, 2026 · Murray
Shingles Vaccine Linked to Lower Dementia Risk in Older Adults
Multiple studies show older adults who received the shingles vaccine faced reduced dementia risk compared to unvaccinated peers. Researchers are investigating whether the vaccine's effect on the immune system or varicella-zoster virus itself explains the association.
France Confirms First Ebola Case
France has confirmed its first case of Ebola virus disease, marking an expansion of the outbreak beyond the Democratic Republic of Congo, where more than 260 people have died.
Sunday, July 19, 2026
Senators push military healthcare system to cover autism therapy
Two senators have called on the military's health insurance program to add autism therapy to its standard benefits after NBC News reported that service members and retirees faced obstacles obtaining coverage for the treatments.
Sunday, July 19, 2026
Cass Report Author Backs Puberty Blocker Trial to Prevent Harm
Dr. Hilary Cass, author of a major report on gender medicine for children, defended a proposed puberty blocker trial, saying the research would prevent more harm than it causes.
Sunday, July 19, 2026
Insurance Denials for Weight Loss Drugs Push Patients to Explore Alternatives
Patients prescribed GLP-1 weight loss medications often face insurance rejections. Those denied coverage can appeal decisions, switch plans, or explore other pathways to obtain the drugs.
Sunday, July 19, 2026
NHS Approves First Drug to Delay Type 1 Diabetes Onset
Britain's National Health Service has approved an immunotherapy drug that delays the onset of type 1 diabetes in children and adults. The treatment extends the timeline before patients need insulin by around three years.
Sunday, July 19, 2026
How UV Exposure Affects Health and What Dermatologists Recommend
The human body needs some ultraviolet radiation for vitamin D production and other functions, but dermatologists warn that prolonged or intense UV exposure increases the risk of skin cancer and other damage.
Sunday, July 19, 2026
FDA Panel Endorses Moderna's mRNA Flu Vaccine for Older Adults
An FDA advisory panel voted to back Moderna's mFlusiva, an mRNA-based flu vaccine designed for older Americans. The approval marks the first time regulators have greenlit a flu shot using messenger RNA technology.
Sunday, July 19, 2026